Webinar Date/Time: Wed, Apr 12, 2023 1:00 PM EDT
Learn how companies are delivering personalized support and the improvements in efficacy and efficiency
Register Free: https://www.pharmexec.com/pe_w/patient-centricity
Event Overview:
With the democratization of information, and the increasing involvement of patients in their own care, biopharma companies are integrating technology and advanced analytics solutions to move from a one-size-fits-all model of patient support to a tailored patient journey that is specific to the needs, expectations, and barriers of patients. The integration of technology into the patient journey has accelerated this transformation – capabilities such as artificial intelligence, connected wearables, telemedicine, virtual reality, augmented reality, and interoperability across service providers – has enabled brands to move away from the traditional, myopic view of the patient to one that is digitally empowered, smart and informed by continued feedback from the patient.
Key Learnings:
Who Should Attend:
Speaker:
Josh Konetzni
SVP and Head of Business Development
VMS BioMarketing
Josh Konetzni has spent his career providing solutions to the healthcare industry across a wide range of technology/data/marketing driven initiatives. He previously held leadership sales, business development, and marketing roles at AdhereTech, MMIT/Norstella, Alliance Health, Remedy Health Media and Undertone. Through Josh’s effort and collaboration, his organizations have partnered with and supported hundreds of top pharmaceutical companies, pharmacies and other healthcare organizations with an ultimate aim of improving outcomes for patients.
He holds an MA in instructional technology and media from Columbia University and a BS in communications, management and design from Ithaca College.
Register Free: https://www.pharmexec.com/pe_w/patient-centricity
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.